Popular Articles

Numbers Of Stroke Caused By Intracerebral Haemorrhage Have Increased By Around A Fifth In The Last Decade
Stokes caused by non-traumatic intracerebral haemorrhage (IH) are caused by a rupture of blood vessels in the brain. This is a major public health problem which accounts for 2 million (10-15%) of a total of 15 million strokes worldwide each year. The causes and the future treatment of this condition are discussed in a Seminar in this week"s edition of The Lancet, written by Dr Adnan I. Qureshi, (Zeenat Qureshi Stroke Research Center, University of Minnesota, USA); Dr A David Mendelow (University of Newcastle, UK); and Dr Daniel F Hanley (Johns Hopkins Medical Institutions, Baltimore, USA).
generic viagra online
August Is National Children's Vision And Learning Month
The College of Optometrists in Vision Development (COVD) is launching their annual campaign to educate the public on the steps they can take to ensure their children aren"t struggling with reading and learning because of undiagnosed vision problems.
News of the day
Family Planning A Major Environmental Impact
Some people who are serious about wanting to reduce their "carbon footprint" on the Earth have one choice available to them that may yield a large long-term benefit - have one less child.
Nutrition

Pharmacists' Association Executive To Receive The Food And Drug Administration's Commissioner's Special Citation Award

John A. Gans, PharmD, Executive Vice President and Chief Executive Officer for the American Pharmacists Association (APhA) has been selected as a recipient of the Food and Drug Administration"s (FDA) Commissioner"s Special Citation Award. The award will be bestowed upon Dr. Gans today during a ceremony at Martin"s Crosswinds, Greenbelt, Maryland. The award is being presented to Dr. Gans in recognition of 20 years of outstanding leadership in ensuring issues of importance to pharmacists and the APhA are considered in FDA regulatory decision-making. In congratulating Gans, Dr. Joshua Sharfstein, Acting Commissioner of Food and Drugs, Principal Deputy Commissioner said, "You have been chosen for this award because you have provided invaluable assistance to the FDA. To be selected for special recognition should be most satisfying since accomplishments such as yours impact the well being of the public." Dr. Gans has been APhA"s Executive Vice President and Chief Executive Officer since 1989, focusing on positioning pharmacists as valued members of the healthcare team who can improve medication use and advance patient care. Prior to joining APhA Gans served on the faculty and was Dean of the School of Pharmacy at the Philadelphia College of Pharmacy and Science (now known as the University of the Sciences in Philadelphia), where he earned his pharmacy degree in l966 and his doctorate in pharmacy in 1969. Dr. Gans began his career in 1966 as a community pharmacist in Broomall, Pennsylvania. During 1967-68, Dr. Gans held a residency at the Hospital of the University of Pennsylvania. Following his residency, he became Assistant Director of Pharmacy at the Hospital of the University of Pennsylvania and held that position from 1968-70. He was a pioneer in the area of parenteral nutrition and clinical pharmacy. From 1974 to 1985, he served as the Managing Director of Pharmaservices, a consultant firm to nursing homes. Dr. Gans has served as the Founding Chairman of the Delaware Valley Regional Poison Control Program, which established a 24-hour regional poison control center in 1985. In 1980-81, he served as President of the Pennsylvania Society of Hospital Pharmacists and, in 1986-87, as President of the American Society of Hospital Pharmacists. Dr. Gans will step down in July as EVP and CEO of APhA after nearly 20 years of service to the organization. American Pharmacists Association (APhA)


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):